170 related articles for article (PubMed ID: 35136977)
1. Gastroparesis in systemic sclerosis: a detailed analysis using whole-gut scintigraphy.
Adler B; Hummers LK; Pasricha PJ; McMahan ZH
Rheumatology (Oxford); 2022 Nov; 61(11):4503-4508. PubMed ID: 35136977
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis.
McMahan ZH; Tucker AE; Perin J; Volkmann ER; Kulkarni S; Ziessman HA; Pasricha PJ; Wigley FM
Arthritis Care Res (Hoboken); 2022 Mar; 74(3):442-450. PubMed ID: 33064934
[TBL] [Abstract][Full Text] [Related]
3. UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis.
Abignano G; Mennillo GA; Lettieri G; Karadag DT; Carriero A; Padula AA; Del Galdo F; Khanna D; D'Angelo S
J Rheumatol; 2021 Sep; 48(9):1422-1426. PubMed ID: 33452163
[TBL] [Abstract][Full Text] [Related]
4. Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit.
Parkman HP; Sharkey E; McCallum RW; Hasler WL; Koch KL; Sarosiek I; Abell TL; Kuo B; Shulman RJ; Grover M; Farrugia G; Schey R; Tonascia J; Hamilton F; Pasricha PJ;
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):546-558.e5. PubMed ID: 33130007
[TBL] [Abstract][Full Text] [Related]
5. Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis.
Hasler WL; May KP; Wilson LA; Van Natta M; Parkman HP; Pasricha PJ; Koch KL; Abell TL; McCallum RW; Nguyen LA; Snape WJ; Sarosiek I; Clarke JO; Farrugia G; Calles-Escandon J; Grover M; Tonascia J; Lee LA; Miriel L; Hamilton FA;
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28872760
[TBL] [Abstract][Full Text] [Related]
6. Baseline Predictors of Longitudinal Changes in Symptom Severity and Quality of Life in Patients With Suspected Gastroparesis.
Lee AA; Rao K; Parkman HP; McCallum RW; Sarosiek I; Nguyen LA; Wo JM; Schulman MI; Moshiree B; Rao S; Kuo B; Hasler WL
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e407-e428. PubMed ID: 32971231
[TBL] [Abstract][Full Text] [Related]
7. Influence of Gastric Emptying and Gut Transit Testing on Clinical Management Decisions in Suspected Gastroparesis.
Hasler WL; Rao SSC; McCallum RW; Krause RA; Nguyen LA; Schulman MI; Lee AA; Moshiree B; Wo JM; Parkman HP; Sarosiek I; Wilding GE; Kuo B
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00084. PubMed ID: 31663906
[TBL] [Abstract][Full Text] [Related]
8. Gastric emptying of solids and liquids for evaluation for gastroparesis.
Sachdeva P; Malhotra N; Pathikonda M; Khayyam U; Fisher RS; Maurer AH; Parkman HP
Dig Dis Sci; 2011 Apr; 56(4):1138-46. PubMed ID: 21365240
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of gastric emptying scintigraphy for the evaluation and management of scleroderma related gastroparesis].
Piskorz MM; Rank G; Velázquez Espeche M; García Cainzo A; Pisarevsky A; Sorda JA; Olmos J
Acta Gastroenterol Latinoam; 2015 Mar; 45(1):56-60. PubMed ID: 26076515
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients.
Suliman YA; Kafaja S; Alemam M; Shaweesh Y; Tavakoli K; Furst DE
J Scleroderma Relat Disord; 2021 Oct; 6(3):236-241. PubMed ID: 35387210
[TBL] [Abstract][Full Text] [Related]
11. Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis.
Marie I; Gourcerol G; Leroi AM; Ménard JF; Levesque H; Ducrotté P
Arthritis Rheum; 2012 Jul; 64(7):2346-55. PubMed ID: 22231388
[TBL] [Abstract][Full Text] [Related]
12. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
[TBL] [Abstract][Full Text] [Related]
13. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
[TBL] [Abstract][Full Text] [Related]
14. Antivinculin Antibodies in Systemic Sclerosis: Associations With Slow Gastric Transit and Extraintestinal Clinical Phenotype.
Herrán M; Adler BL; Perin J; Morales W; Pimentel M; McMahan ZH
Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2166-2173. PubMed ID: 36951252
[TBL] [Abstract][Full Text] [Related]
15. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
[TBL] [Abstract][Full Text] [Related]
16. Relationship of gastrointestinal symptoms and psychosocial distress to gastric retention in children.
Wong GK; Shulman RJ; Malaty HM; Czyzewski D; Seghers VJ; Thompson D; Chumpitazi BP
J Pediatr; 2014 Jul; 165(1):85-91.e1. PubMed ID: 24726541
[TBL] [Abstract][Full Text] [Related]
17. Relationships among intragastric meal distribution during gastric emptying scintigraphy, water consumption during water load satiety testing, and symptoms of gastroparesis.
Parkman HP; Wilson LA; Silver P; Maurer AH; Sarosiek I; Bulat RS; Kuo B; Grover M; Farrugia G; Chumpitazi BP; Shulman RJ; Malik Z; Miriel LA; Tonascia J; Hamilton F; Abell TL; Pasricha PJ; McCallum RW; Koch KL;
Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G407-G417. PubMed ID: 37552206
[TBL] [Abstract][Full Text] [Related]
18. Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study.
Cozzi F; Parisi G; Ciprian L; Bullo A; Cardarelli S; Rizzo M; Sfriso P; Punzi L
Rheumatol Int; 2012 May; 32(5):1219-23. PubMed ID: 21258796
[TBL] [Abstract][Full Text] [Related]
19. Measurement of gastric emptying by radiopaque markers in patients with diabetes: correlation with scintigraphy and upper gastrointestinal symptoms.
Olausson EA; Brock C; Drewes AM; Grundin H; Isaksson M; Stotzer P; Abrahamsson H; Attvall S; Simrén M
Neurogastroenterol Motil; 2013 Mar; 25(3):e224-32. PubMed ID: 23316944
[TBL] [Abstract][Full Text] [Related]
20. Validation of Diagnostic and Performance Characteristics of the Wireless Motility Capsule in Patients With Suspected Gastroparesis.
Lee AA; Rao S; Nguyen LA; Moshiree B; Sarosiek I; Schulman MI; Wo JM; Parkman HP; Wilding GE; McCallum RW; Hasler WL; Kuo B
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1770-1779.e2. PubMed ID: 30557741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
